Exclusive Healthcare Investment Opportunities

July2025 Pipeline

Top 10

Investment Bank

Real-Time View of MHA's M&A & Capital Raise Deal Flow

Please see below for a pipeline of Merritt Healthcare Advisor’s Active, Near Term (<3 months to Active), and Upcoming (>3 months to Active) transactions. 

Filter by term

Pipeline Transactions

Active

Medical Practices > Other Specialties

NYC mental health business seeking $15M-$20M in debt financing. Collateral package will include business cashflow and owner’s net worth. Ownership is willing to match investors dollar for dollar for their investment.

Near Term

Health Technology

Early mover in the patient navigation space. Product is designed to support data entry, tracking and evaluation across multiple therapeutic areas. The tool provides a convenient method of documenting navigator care and reimbursable events while supporting timely & efficient patient care, fitting into VBC trends and taking advantage of recent reimbursement changes. Revenue producing and seeking $5M in growth capital.

Active

Health Technology

Precision Oncology company integrating explainable AI, spatial biology, and predictive analytics to define patient-specific biomarkers of response to existing and emerging therapies. Their proprietary platform leverages multi-modal data to support clinical trials, accelerating therapeutic decisions and de-risking drug development. The Company is forcasted to generate $14M+ in 2026.

Active

Health Technology

AI company focused on pathology research acceleration. Has been engaged with a multinational pharmaceutical company conducting a case study for several year and is ready to accelerate growth seeking $10M+ in capital.

Upcoming

Biopharma

Pharmaceutical manufacturing company producing liquid drugs (including GLP- 1 RAs, Saline Solution, and Naloxone) seeking $250M in capital to develop a state-of-the-art 50,000+ sqft. manufacturing facility and purchase equipment.

Near Term

Biopharma

Regenerative therapeutics company that specializes in developing skin graft for surgical & wound care applications seeking $25M in capital to expand operations and develop more products, and company currently generating $10M+ in Revenue.

Active

Biopharma

Gene & cell therapy platform focused on developing treatments for rare & incurable diseases with extensive IP portfolio seeking to raise $15M+ to complete the next phase of clinical trials. Lead product is an HIV treatment that has completed 2 U.S. clinical trials and demonstrated safety & efficacy signals.

In Exclusivity

Surgical Facilities

Cardiovascular specialty ASC in Dallas/Fort Worth area.

In Exclusivity

Surgical Facilities

Multispecialty ASC with 4 OR’s & 1 PR in Westchester, NY.

In Exclusivity

Surgical Facilities

Portfolio of 15+ west coast ASC’s & Surgical Hospitals.

Upcoming

Surgical Facilities

Ophthalmology & Plastic Surgery ASC equipped with 4 OR’s & 1 PR’s in Michigan with $2.2M+ in EBITDA.

Active

Surgical Facilities

Multispecialty ASC equipped with 5 OR’s & 2 PR’s in Chicago with $11M+ in Revenue.

Active

Surgical Facilities

Portfolio of 11 ASC’s & 5 Endoscopy Centers (with Management Companies) in Northern & Southern California with ~$30M in EBITDAM. Several sites are in early operations & ramping.

Near Term

Medical Practices > Other Specialties

Physician/APP wound and palliated care for skilled nursing and other types of facilities with over 30 providers generating $24M+ in revenues in multiple U.S. states.

Active

Medical Practices > Other Specialties

Ophthalmology practice in North Dakota & Minnesota with 5 providers and $2.8M+ in adjusted EBITDA.

Near Term

Multispecialty > Medical Practices

Multispecialty medical group in California with 400+ providers and 180+ office locations, generating ~$40M in EBITDA

Upcoming

Medical Practices > Primary Care & Related Specialties

Sports Medicine & Family Medicine practice with Urgent Care and Physical Therapy, 50+ providers, and 5 office locations in Southern California with $4M+ in EBITDA.

Active

Medical Practices > Primary Care & Related Specialties

Pediatric Practice with 9 providers and 2 office locations in South Carolina generating ~$1.5M in EBITDA.

Active

Primary Care & Related Specialties > Medical Practices

B2B/employer focused onsite/telehealth provider headquartered in Texas that delivers primary, specialty, and acute care services to 30,000+ lives. Operating in 10 locations across 2 states, producing $3M+ in EBITDA.

Active

Primary Care & Related Specialties > Medical Practices

Neurology and Primary Care Practice with 6 providers, 4 office locations in West Virginia producing $3.6M in EBITDA.

In Exclusivity

Musculoskeletal > Medical Practices

South Florida Podiatry group with 15+ locations.

In Exclusivity

Musculoskeletal > Medical Practices

Connecticut Orthopedic practice & ASC.

Upcoming

Musculoskeletal > Medical Practices

Pain Management practice in Northern California generating $2M+ in Revenue.

Matt Searles, MBA Partner msearles@merrittadvisory.com Rich Searles Partner rsearles@merrittadvisory.com

Upcoming

Musculoskeletal > Medical Practices

Orthopedic practice with 10+ providers and 3 office locations in the San Francisco Bay Area generating $14M+ in Revenue.

Matt Searles, MBA Partner msearles@merrittadvisory.com Rich Searles Partner rsearles@merrittadvisory.com

Active

Musculoskeletal > Medical Practices

Orthopedic & Sports Medicine practice & ASC in New Hampshire with 5 locations generating $2.5M+ in EBITDA.

Active

Musculoskeletal > Medical Practices

Podiatry practice in Minnesota & Texas with 8 podiatrists and 7 office locations, producing $5.1M+ in EBITDA.

Active

Musculoskeletal

Spine & Pain Management practice & ASC in Northern California with 5 locations, generating ~$7M in EBITDA.

Active

Musculoskeletal

Workers’ compensation specialty Orthopedic practice & ASC in Southern California generating $15M+ in EBITDA.

Active

Cardiovascular > Medical Practices

New York City Cardiovascular practice with 15 providers generating $4M+ in EBITDA. In process of converting its existing OBL to an ASC.

Please enter email address to access Merritt’s updated deal pipeline

Schedule Your Appointment Today

The Industry’s LeadingHeathcare Advisory Firm

Gain insights from the healthcare industry’s leading M&A experts

Merritt Healthcare Advisors (“MHA”) is focused exclusively on representing owners of middle-market healthcare businesses considering strategic options, whether selling an interest in their organization, creating a new partnership or growing through acquisition.